Nasdaq Delists Biotech Firm Windtree After $700M BNB Treasury Play Fails To Boost Stock
1 day ago
2
ARTICLE AD BOX
Windtree Therapeutics is being kicked off from Nasdaq, roughly a month after its $700 million pivot into a digital treasury firm focused on BNB token failed.